Thymosin Alpha-1 5mg (10 Vials)

Overview

Thymosin Alpha-1 (Tα1) is a synthetic peptide used in laboratory studies of immune signaling, receptor interactions, and experimental model behavior. Any references to biological activity are provided strictly for research context and must not be interpreted as claims of safety, efficacy, or intended human use.

Thymosin Alpha-1 : Structure

Sequence: Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn

Molecular Formula: C₁₂₉H₂₁₅N₃₃O₅₅

Molecular Weight: 3108.315 g/mol

PubChem CID: 16130571

CAS Number: 62304-98-7

Synonyms: Thymalfasin

Source: PubChem

Research Characteristics

Tα1 is studied in controlled laboratory settings to examine immune-marker responses, cytokine signaling, antigen presentation, and receptor-level interactions. This product is supplied for research purposes only and is not offered for human or veterinary use.

Why Researchers Choose Thymosin Alpha-1 (Tα1) 5 mg

• High-purity, laboratory-grade formulation

• Lyophilized powder supporting structural stability and predictable reconstitution

• Batch-tested to ensure reproducibility, consistency, and peptide integrity

• Backed by decades of published immune-mechanism literature

• Suitable for mechanistic, biochemical, and cellular-level experimentation

• 5 mg format allows controlled design of concentration-specific protocols

The careful production and testing standards associated with Tα1 make it a valuable asset to research laboratories focused on immune-relevant systems.

Why Choose Licensed Peptides for Thymosin Alpha-1 5 mg (10 vials)?

Licensed Peptides is committed to providing research laboratories with high-quality Tα1 produced under stringent quality-assurance protocols. Every vial is formulated, sealed, and packaged exclusively for laboratory use, ensuring that peptide integrity is protected throughout storage, handling, and transport.

Our Commitment to Research Facilities

• U.S.-based fulfillment for reliable, timely delivery

• Secure, professional packaging designed for lyophilized peptide protection

• Fast, encrypted online ordering with major credit/debit card acceptance

• Rapid processing to support uninterrupted laboratory workflow

All products supplied by Licensed Peptides are intended solely for controlled scientific experimentation. They are not approved for clinical, therapeutic, diagnostic, or cosmetic applications.

Frequently Asked Questions (FAQ)

(For Research Use Only – Not for Human or Animal Use)

Q1: What is Thymosin Alpha-1 used for in research?

It is commonly utilized to study immune signaling, T-cell communication, cytokine behavior, and coordinated immune-response dynamics under controlled experimental conditions.

Q2: How does Thymosin Alpha-1 function in research models?

In laboratory assays, Tα1 is observed interacting with immune receptors, influencing cytokine expression, and supporting studies related to T-cell maturation and immune pathway mapping.

Q3: Is Thymosin Alpha-1 considered an immune “booster” in research?

No. Research frameworks describe it as a modulatory agent rather than a purely stimulatory one, making it useful for observing balanced immune-signaling shifts rather than uniform intensification.

Q4: What is the concentration of the supplied vial?

Each vial contains 5 mg of research-grade, lyophilized Thymosin Alpha-1 designed for controlled reconstitution in laboratory environments.

Q5: Can Tα1 be used in multi-compound experiments?

Yes. It is frequently incorporated into studies examining combined molecular effects, synergistic interactions, and comparative immune-pathway analysis.

Q6: How should Thymosin Alpha-1 be stored for research use?

Laboratories typically store the lyophilized vials under refrigerated conditions. After reconstitution, many research teams maintain cold storage to support structural stability.

Q7: What is known about Tα1’s safety in research environments?

Published scientific literature describes tolerability observations in controlled research models. This does not imply suitability for human or animal use.

Q8: Is Thymosin Alpha-1 appropriate for clinical or therapeutic applications?

No. It is not approved for any clinical, therapeutic, diagnostic, or cosmetic applications and is intended strictly for laboratory experimentation.

Q9: Which research fields most frequently incorporate Tα1?

Immunology, inflammation biology, molecular signaling studies, and cellular immunomodulation research commonly employ Tα1 in controlled experiments.

Q10: How long does Thymosin Alpha-1 remain stable?

When stored in cool, dark conditions, Tα1 maintains structural integrity for extended research timelines, making it suitable for ongoing experimental protocols.

Q11: What does LPS-free peptide mean for Thymosin Alpha-1 5 mg?

An LPS-free peptide indicates that the product is manufactured to minimize lipopolysaccharide contamination, which is critical for immune and cell-signaling research where endotoxins could interfere with experimental results.

Q12: Why is an endotoxin-free peptide important in research applications?

An endotoxin-free peptide helps ensure that observed immune or cellular responses arise from the peptide itself rather than from contaminating endotoxins, supporting cleaner data interpretation in laboratory studies.

Q13: Are research peptides endotoxin tested before release?

Yes. Thymosin Alpha-1 5 mg is part of a category where research peptides are endotoxin tested to meet laboratory standards for purity, consistency, and experimental reliability.

Thymosin Alpha-1 : Research Context

Published studies on Tα1 are referenced here for scientific background only. They describe findings in cell and experimental models and do not imply therapeutic, diagnostic, or clinical benefit.

Referenced Citations

Xu, Y., Jiang, Y., Wang, L., Huang, J., Wen, J., Lv, H., Wu, X., Wan, C., Yu, C., Zhang, W., Zhao, J., Zhou, Y., & Chen, Y. (2019). Thymosin Alpha-1 Inhibits Complete Freund’s Adjuvant-Induced Pain and Production of Microglia-Mediated Pro-inflammatory Cytokines in Spinal Cord. Neuroscience bulletin, 35(4), 637–648. https://doi.org/10.1007/s12264-019-00346-z

Romani, L., Oikonomou, V., Moretti, S., Iannitti, R. G., D’Adamo, M. C., Villella, V. R., Pariano, M., Sforna, L., Borghi, M., Bellet, M. M., Fallarino, F., Pallotta, M. T., Servillo, G., Ferrari, E., Puccetti, P., Kroemer, G., Pessia, M., Maiuri, L., Goldstein, A. L., & Garaci, E. (2017). Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis. Nature medicine, 23(5), 590–600. https://doi.org/10.1038/nm.4305

King R, Tuthill C. Immune Modulation with Thymosin Alpha 1 Treatment. Vitam Horm. 2016;102:151-178. doi:10.1016/bs.vh.2016.04.003

Matteucci C, Grelli S, Balestrieri E, et al. Thymosin alpha 1 and HIV-1: recent advances and future perspectives. Future Microbiol. 2017;12:141-155. doi:10.2217/fmb-2016-0125

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products available on this website are intended solely for in-vitro research purposes (Latin: “in glass”), meaning they are used in experiments conducted outside a living organism. These products are not medicines or drugs, have not been evaluated or approved by the U.S. Food and Drug Administration (FDA), and are not intended to diagnose, treat, cure, or prevent any disease or medical condition. Any administration to humans or animals, whether by ingestion, injection, or other means, is strictly prohibited by law.